Daridorexant 25 mg, 50 mg Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 25 mg, 50 mg
Reference Brands: Quviviq (USA/EU)
Category: Neurology
Daridorexant is a Neurology product available as Tablets in strengths 25 mg, 50 mg. It corresponds to the reference brand Quviviq (USA/EU). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.
Product Description:
Daridorexant, marketed under the brand name Quviviq, is an oral medication approved for the treatment of insomnia in adults, specifically for those experiencing difficulties with sleep onset and/or sleep maintenance. As a dual orexin receptor antagonist (DORA), daridorexant works by selectively blocking orexin receptors OX1 and OX2, helping to regulate the sleep-wake cycle and promote restful, continuous sleep.
Clinical studies have demonstrated that daridorexant significantly improves multiple measures of sleep. At doses of 25 to 50 mg, it reduces latency to persistent sleep (LPS) by 6 to 12 minutes, decreases wake after sleep onset (WASO) by 10 to 23 minutes, and increases subjective total sleep time (TST) by 10 to 22 minutes compared with placebo. Furthermore, at the 50 mg dose, daridorexant has been shown to enhance daytime functioning, supporting better alertness and cognitive performance during waking hours.
Taken orally once daily before bedtime, daridorexant provides a modern, targeted approach to insomnia management with a favorable tolerability profile. It offers patients a safe and effective option for improving both nighttime sleep quality and overall daytime well-being.
Daridorexant — third party manufacturing & bulk supply
Daridorexant 25 mg, 50 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Daridorexant listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Daridorexant →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Daridorexant is used for the treatment of insomnia in adults, helping to improve sleep onset, sleep maintenance, and overall sleep quality.
Daridorexant is a synthetic small-molecule dual orexin receptor antagonist (DORA) designed to block OX1 and OX2 receptors, thereby modulating the sleep-wake cycle.
The trade name of daridorexant is Quviviq.
Quviviq is developed and marketed by Idorsia Pharmaceuticals.
The complete generic name is daridorexant.
The brand name is Quviviq.
Daridorexant tablets are manufactured in regulatory-approved pharmaceutical facilities for the USA, EU, and UK markets, with production and quality standards managed by Idorsia Pharmaceuticals.
Related Products
Valproic Acid
Strength:
125 mg/mL, 200 mg, 250 mg, 300 mg, 500 mg, 100 mg/mL
Form: Tablet / Capsule/ Injection / Oral syrup
Reference Brands: Depakene (USA), Depakine (EU/LATAM), Valprol (India)
View Details
Quick Response Guaranteed | Verified Suppliers
